Buscar resultados de ensayos clínicos
Germinoma - 51 Studies Found
Estado | Estudiar |
Active, not recruiting |
Nombre del estudio: Screening for Ovarian Cancer in Older Patients (PLCO Screening Trial) Condición:
Fecha: 2012-09-28 Intervenciones:
|
Recruiting |
Nombre del estudio: Standard-Dose Combination Chemotherapy or High-Dose Combination Chemotherapy and Stem Cell Transplant in Treating Patients With Relapsed or Refractory Germ Cell Tumors Condición:
|
Completed |
Nombre del estudio: Combination Chemotherapy in Treating Young Patients With Advanced Solid Tumors Condición:
|
Completed |
Nombre del estudio: Sunitinib in Treating Young Patients With Refractory Solid Tumors Condición:
Intervenciones: |
Terminated |
Nombre del estudio: Gamma-Secretase Inhibitor RO4929097 in Treating Young Patients With Relapsed or Refractory Solid Tumors, CNS Tumors, Lymphoma, or T-Cell Leukemia Condición:
|
Completed |
Nombre del estudio: Vorinostat and Temozolomide in Treating Young Patients With Relapsed or Refractory Primary Brain Tumors or Spinal Cord Tumors Condición:
|
Completed |
Nombre del estudio: Vorinostat and Bortezomib in Treating Young Patients With Refractory or Recurrent Solid Tumors, Including Central Nervous System Tumors and Lymphoma Condición:
|
Completed |
Nombre del estudio: Pazopanib Hydrochloride in Treating Young Patients With Solid Tumors That Have Relapsed or Not Responded to Treatment Condición:
|
Completed |
Nombre del estudio: ARQ 197 for Subjects With Relapsed or Refractory Germ Cell Tumors Condición: Non-CNS Germ Cell Tumors (Seminomas and Nonseminomas) Fecha: 2010-01-21 Intervenciones: Drug: Tivantinib (ARQ 197) Capsule, 120 mg, BID (360 mg), approximately 112 days |
Completed |
Nombre del estudio: Darbepoetin Alfa in Patients With "Poor Prognosis" Germ Cell Tumor Treated With High-Dose Chemotherapy (HD-VIP) Condición: Dysgerminoma Fecha: 2005-09-13 Intervenciones: Drug: Darbepoetin alfa |